Among the nine cases of ADC that acquired β-catenin alterations in the metastatic tumors, six cases (66.7%) were accompanied by a reduction in E-cadherin expression, and there was only one case (11.1%) in which Wnt1 overexpression was detected in the metastatic tumor. Here, CDH1 is linked to metastatic neoplasm.